DETAILED NOTES ON BI8622

OMEPRAZOLE: There were no alterations from the pharmacokinetic parameters of both cerivastatin or its key active metabolites, or of omeprazole in wholesome young males given one 0.3 mg oral doses of cerivastatin alone or on the fifth day of the 5-day omeprazole twenty mg day-to-day pre-treatment method.Rhabdomyolysis with renal dysfunction secondar